Mark James Litton, Chief Business Officer at ALDER BIOPHARMACEUTICALS INC (ALDR), sold 6,000 shares at $27.50 ($165K) on 2016-10-17, disclosed to the SEC on 2016-10-19.
Open-market sale of $165k ALDR by Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $27.50 | 2,000 | $55K | 33.3% |
| 2 | $27.50 | 2,000 | $55K | 33.3% |
| 3 | $27.50 | 2,000 | $55K | 33.3% |
| Total | $27.50 avg | 6,000 | $165K | 100% |
| Filing → |
| ALDR | SELL | 2017-01-09 | $219K | — | Filing → |
| ALDR | SELL | 2016-06-15 | $171K | — | Filing → |
| ALDR | SELL | 2016-06-01 | $751K | — | Filing → |